Have a plan for problems

For severe allergic symptoms, get urgent help

Confusing measurements need a real answer

Medicine reviews and drug alerts come from the Food and Drug Administration (FDA).

FDA-approved semaglutide is the drug in Ozempic and Wegovy, as checked September 26, 2026.

FDA warnings checked September 26, 2026 describe harm reports possibly linked to measurement mistakes with made-to-order semaglutide injections.

Some reports involved hospital care.

Bring an unclear label or conflicting instructions to the prescriber and pharmacist for an explanation.

Ask how to reach the prescriber after the medicine arrives.

Ask about this product’s storage

The product’s written information

Storage instructions differ by medicine. The guide’s notes checked September 17, 2026 include medicines kept cold and others kept at room temperature.

GLP-1 drugs are a group of weight and diabetes medicines that copy a body signal.

FDA advice checked September 17, 2026 applies to GLP-1 injections. Do not use medicine delivered warm or without enough cooling to keep it at its labelled temperature.

If the cold packs have warmed up, ask the pharmacy whether the delivery met this medicine’s temperature rules before using it.

Ask the pharmacy how to store the specific medicine that reaches you.

Tell the prescriber about breastfeeding, a current pregnancy, or plans to become pregnant.

A suspected problem can be reported

MedWatch lets patients and health professionals report medicine problems to FDA. The guide checked this service September 17, 2026.

Reporting a problem does not establish that it was caused by the medicine.